Effect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure (SANDI STUDY)

Not yet recruitingOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Heart FailurePersistent Congestion
Interventions
DRUG

Standarized diuretic therapy

Patients hospitalized with decompensated heart failure and fluid overload who require diuretic treatment for relieve of congestion. Standarized diuretic protocol according to guidelines will be applied. It consists of intravenous furosemide, SGLT2 inhibitors and acetazolamide if congestion persist.

Trial Locations (1)

28222

Julia González González, Madrid

All Listed Sponsors
collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

Hospital Central de la Defensa Gómez Ulla

OTHER

collaborator

Hospital Vall d'Hebron

OTHER

collaborator

Hospital Universitario Ramon y Cajal

OTHER

collaborator

University Hospital of Girona Dr. Josep Trueta

NETWORK

collaborator

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

OTHER

lead

Puerta de Hierro University Hospital

OTHER

NCT06285760 - Effect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure (SANDI STUDY) | Biotech Hunter | Biotech Hunter